A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

NCT05987371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: TQC3721 suspension for inhalation
DRUG: TQC3721 matching placebo for inhalation
DRUG: Salbutamol sulfate inhalation aerosol

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.